Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries, Ltd.filedCriticalTakeda Chemical Industries, Ltd.
Publication of TR200003299T2publicationCriticalpatent/TR200003299T2/en
Mevcut bulus hipoglisemik etkiye ve hipolipidemik etkiye sahip yeni oksiiminoalkanoik asit türevlerine, bir oksiiminoalkanoik asit ihtiva eden yeni bir farmasötik bilesime ve retinoit baglantili reseptör fonksiyonu düzenleyicisine iliskindir. Bu tür yeni oksiiminoalkanoik asit türevleri, farmasötik bilesimler ve retinoit baglantili reseptör fonksiyonu düzenleyiciler seker hastaligi, hiperlipidemi, azalan glükoz toleransi, enflamatuvar hastalik, arterioskleroz ve benzerinin önlenmesine ve/veya tedavisine mahsus bir ajan olarak faydalidirlar.The present invention relates to new oxyiminoalkanoic acid derivatives with hypoglycemic effect and hypolipidemic effect, a new pharmaceutical composition containing an oxyiminoalkanoic acid, and a retinoid-linked receptor function regulator. Such novel oxyiminoalkanoic acid derivatives, pharmaceutical compositions, and retinoid-linked receptor function regulators are useful as agents for the prevention and / or treatment of diabetes, hyperlipidemia, decreased glucose tolerance, inflammatory disease, arteriosclerosis, and the like.